tak-653
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 14, 2015 (NCT02561156)
Timeline
Indications
Mechanism of action
GRIP1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tak-653
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03792672 | Phase 1 | Feb 11, 2019 | Millennium Pharmaceuticals |
| NCT03312894 | Phase 2 | Feb 15, 2018 | Millennium Pharmaceuticals, Takeda |
| NCT02561156 | Phase 1 | Sep 14, 2015 | Takeda |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Millennium Pharmaceuticals | For profit | 2 | 2 | 2 | 2018 |
| Takeda | For profit | 2 | 1 | 2 | 2015 |
2 organizations
Page 1 / 1